Arnold L. Oronsky
Board Member
ONCOLOGY
Sera Prognostics
Denmark
Biography
Dr. Oronsky is a general partner leading healthcare investments at InterWest Partners, LLC. He has significant experience investing in diagnostic and pharmaceutical companies and has served on numerous boards of successful healthcare companies that address significant unmet medical needs through innovative technologies. Dr. Oronsky currently serves on the boards of Applied Genetic Technologies Corporation (AGTC), Arcion, Centrexion, Drais Pharmaceuticals, Dynavax Technologies (DVAX), Integrated Diagnostics, PMV Pharma, Potenza Theraputics, EpicentRx, and TESARO (TSRO). Prior to joining InterWest Partners, Dr. Oronsky led pharmaceutical research as vice president for discovery research of the Lederle Laboratories division of American Cyanamid Company. He earned a Ph.D. in immunology from Columbia University and is currently a senior lecturer at the Department of Medicine at Johns Hopkins Medical School.
Research Interest
Oncology specialist,
